PD1 Stock Overview
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Ansell Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$56.00 |
| 52 Week High | AU$64.50 |
| 52 Week Low | AU$46.20 |
| Beta | 0.50 |
| 1 Month Change | 5.66% |
| 3 Month Change | 0.90% |
| 1 Year Change | -11.11% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -45.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| PD1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 3.7% | 2.1% | 0.5% |
| 1Y | -11.1% | -8.4% | 1.3% |
Return vs Industry: PD1 underperformed the German Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: PD1 underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| PD1 volatility | |
|---|---|
| PD1 Average Weekly Movement | 4.6% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PD1 has not had significant price volatility in the past 3 months.
Volatility Over Time: PD1's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1893 | 14,000 | Neil Salmon | www.ansell.com |
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies.
Ansell Limited Fundamentals Summary
| PD1 fundamental statistics | |
|---|---|
| Market cap | €2.18b |
| Earnings (TTM) | €96.76m |
| Revenue (TTM) | €1.50b |
22.6x
P/E Ratio1.5x
P/S RatioIs PD1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PD1 income statement (TTM) | |
|---|---|
| Revenue | US$1.60b |
| Cost of Revenue | US$995.00m |
| Gross Profit | US$609.70m |
| Other Expenses | US$505.90m |
| Earnings | US$103.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 20, 2024
| Earnings per share (EPS) | 0.73 |
| Gross Margin | 37.99% |
| Net Profit Margin | 6.47% |
| Debt/Equity Ratio | 26.7% |
How did PD1 perform over the long term?
See historical performance and comparison